医学
外显率
肥厚性心肌病
内科学
基因检测
价值(数学)
遗传学
遗传变异
表型
精密医学
维加维斯
多基因风险评分
全基因组关联研究
个性化医疗
基因型
基因
等位基因
突变
医学遗传学
多基因
梅德林
杂合子优势
计算生物学
生物信息学
作者
Sarah Abramowitz,Lily Hoffman‐Andrews,David Y. Zhang,Renae Judy,Thomas P. Cappola,S. Day,Nosheen Reza,Anjali Owens,Scott M. Damrauer,Michael G. Levin,Penn Medicine BioBank,Daniel J Rader,Marylyn D Ritchie,JoEllen Weaver,Nawar Naseer,Giorgio Sirugo,Afiya Poindexter,Jenna Dever,Aidan Harvey,Sydney Linn
出处
期刊:JAMA Cardiology
[American Medical Association]
日期:2025-12-23
卷期号:11 (2): 147-147
被引量:1
标识
DOI:10.1001/jamacardio.2025.4739
摘要
The findings in this study indicate that HCM and DCM risk were modified by polygenic background, which exists on an overlapping but opposing spectrum. Consideration of polygenic background may offer clinical value through improving understanding and prediction of these inherited cardiomyopathies.
科研通智能强力驱动
Strongly Powered by AbleSci AI